BioCentury
ARTICLE | Regulation

Pending RAC changes

August 29, 1994 7:00 AM UTC

WASHINGTON - Proposals for streamlined procedures for human gene therapy protocols, eliminating overlap between the NIH's Recombinant DNA Advisory Committee and the FDA, will be discussed at the RAC's meeting on Sept. 12-13.

The proposals, published last week in the Federal Register, emanate from a July meeting of the National Task Force on AIDS Drug Development, which was held to indentify barriers to AIDS drug discovery. Task Force members recommended that the dual review process for human gene transfer be consolidated "to elimanate any unnecessary overlap between the FDA and NIH review of human gene transfer proposals."...